Edition:
United States

Ambu A/S (AMBUb.CO)

AMBUb.CO on Copenhagen Stock Exchange

522.50DKK
15 Dec 2017
Change (% chg)

kr.1.50 (+0.29%)
Prev Close
kr.521.00
Open
kr.519.00
Day's High
kr.524.00
Day's Low
kr.515.00
Volume
41,600
Avg. Vol
79,738
52-wk High
kr.595.00
52-wk Low
kr.270.00

Chart for

About

Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area... (more)

Overall

Beta: 0.58
Market Cap(Mil.): kr.22,520.23
Shares Outstanding(Mil.): 43.10
Dividend: 1.85
Yield (%): 0.35

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-Ambu A/S says to issue up to 1.3 mln B shares in private placement

* Reg-Ambu A/S: Ambu A/S to issue up to 1,255,000 B shares in a private placement Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

Nov 14 2017

BRIEF-Ambu Q4 2016/17 EBIT up at DKK ‍134​ million

* Q4 2016/17 EBIT DKK ‍134​ MILLION VERSUS DKK 131 MILLION YEAR AGO

Nov 09 2017

BRIEF-Ambu buys Invendo Medical for EUR 225 million

* REG-AMBU ACQUIRES INVENDO MEDICAL AND ENTERS MARKET OF 70 MILLION GASTRO PROCEDURES ANNUALLY

Oct 25 2017

BRIEF-Ambu plans to ‍generate an EBIT margin of 24-25 pct in 2020

* ‍TOWARDS 2020 AMBU PLANS TO GROW ORGANICALLY BY 13-15% ANNUALLY AND EXPAND EBIT-MARGIN BY MORE THAN 5%-PTS​

Oct 04 2017

BRIEF-Ambu Q3 2016/17 EBIT up at DKK 130 million

* ‍OUTLOOK IS NOW FOR ORGANIC GROWTH OF APPROX. 14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 12-14%​

Aug 23 2017

Earnings vs. Estimates